https://www.fool.com/investing/2017/10/03/how-risky-is-gw-pharmaceuticals-stock-after-zogeni.aspx
How Risky Is GW Pharmaceuticals Stock After Zogenix's Big News? | The Motley Fool
Oct 3, 2017 - Zogenix's gain means GW Pharma's pain. But are fears for the once-hot marijuana stock overblown?
the motley foolgw pharmaceuticalsbig newsriskystock
https://www.eastgateip.com/canopy-growth-sues-gw-pharmaceuticals-for-infringing-cannabis-patent/
Canopy Growth sues GW Pharmaceuticals for Infringing Cannabis Patent - Eastgate IP
Dec 29, 2020 - Canopy Growth has filed suit alleging that GW Pharmaceuticals’ process for producing Epidiolex infringes Canopy’s cannabis extraction patent.
canopy growthgw pharmaceuticalssuesinfringingcannabis
https://marijuanastocks.com/gw-pharmaceuticals-gwph-reports-financial-results-and-operational-progress-for-the-second-quarter-ended-june-30-2019/
GW Pharmaceuticals (GWPH) Reports Financial Results and Operational Progress for the Second Quarter...
Aug 7, 2019 - – Epidiolex U.S. Q2 net sales of $68.4 million – – Positive…
gw pharmaceuticalsfinancial resultsfor thesecond quarterreports
https://www.globenewswire.com/news-release/2015/10/27/780293/10154119/en/GW-Pharmaceuticals-and-Otsuka-Announce-Results-From-Two-Remaining-Sativex-R-Phase-3-Cancer-Pain-Trials.html
GW Pharmaceuticals and Otsuka Announce Results From Two
- Consistent with previously announced results from the initial Phase 3 trial, remaining trials fail to show superiority over placebo -...
gw pharmaceuticalsotsukaannounceresultstwo
https://extraetf.com/at/stock-profile/US36197T1034?tab=brokers
GW Pharmaceuticals PLC Aktie | Kurs | Dividende | Nachrichten (A1T980, US36197T1034)
GW Pharmaceuticals PLC (ISIN: US36197T1034, WKN: A1T980): ✓ Kurs der GW Pharmaceuticals PLC Aktie ✓ Dividenden-Rendite und Termine, ✓ aktuelle Nachrichten ✓...
gw pharmaceuticalsplcaktiekursdividende
https://www.schaeffersresearch.com/content/news/2015/12/24/gw-pharmaceuticals-plc-gwph-drug-data-bursts-bears-bubble
GW Pharmaceuticals PLC (GWPH) Drug Data Bursts Bears' Bubble
Analysts are seemingly the only ones with faith in GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH)
gw pharmaceuticalsplcdrugdatabursts